The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Randomized, Double-Blind Placebo-Controlled Trial of Coenzyme Q10 in Patients with Acute Myocardial Infarction
Abstract
The effects of oral treatment with coenzyme Q10 (120 mg/d) were compared for 28 days in 73 (intervention group A) and 71 (placebo group B) patients with acute myocardial infarction (AMI). After treatment, angina pectoris (9.5 vs. 28.1), total arrhythmias (9.5% vs. 25.3%), and poor left ventricular function (8.2% vs. 22.5%) were significantly (P < 0.05) reduced in the coenzyme Q group than placebo group. Total cardiac events, including cardiac deaths and nonfatal infarction, were also significantly reduced in the coenzyme Q10 group compared with the placebo group (15.0% vs. 30.9%, P < 0.02). The extent of cardiac disease, elevation in cardiac enzymes, and oxidative stress at entry to the study were comparable between the two groups. Lipid peroxides, diene conjugates, and malondialdehyde, which are indicators of oxidative stress, showed a greater reduction in the treatment group than in the placebo group. The antioxidants vitamin A, E, and C and beta-carotene, which were lower initially after AMI, increased more in the coenzyme Q10 group than in the placebo group. These findings suggest that coenzyme Q10 can provide rapid protective effects in patients with AMI if administered within 3 days of the onset of symptoms. More studies in a larger number of patients and long-term follow-up are needed to confirm our results.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinical evidence suggests that CoQ 9 and CoQ 10 also possess cardioprotective properties, preventing ischemic damage to heart tissue and reducing ventricular dysfunction and cardiac arrhythmias associated with heart failure and acute myocardial infarction (44)(45)(46).”
From Lipidomics reveals a remarkable diversity of lipids in human plasma (2010) · cites this paper as [45]
Citations
Cites
[42] Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal
Esterbauer, H., & Cheeseman, K. H. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86134-h · Cited by 3,345
Bernier, M., Hearse, D. J., & Manning, A. S. (1986) · Circulation Research · doi:10.1161/01.res.58.3.331 · Cited by 392
Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis.
Lunec, J., Halloran, S., White, A. G., & Dormandy, T. L. (1981) · PubMed · Cited by 283
Vuilleumier, J. P., Keller, H., Gysel, D., & Hunziker, F. (1983) · PubMed · Cited by 221
The participation of coenzyme Q in free radical production and antioxidation
Beyer, R. E. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90154-b · Cited by 209
Soja, A. M. B., & Mortensen, S. A. (1997) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(97)00042-3 · Cited by 150
Wilkinson, P., Sayer, J., Laji, K., Grundy, C., Marchant, B., Kopelman, P., & Timmis, A. (1996) · BMJ · doi:10.1136/bmj.312.7042.1330 · Cited by 139
Baggio, E., Gandini, R., Plancher, A. C., Passeri, M., & Carmosino, G. (1994) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(94)90040-x · Cited by 130
Relative bioavailability of coenzyme Q10 formulations in human subjects.
Chopra, R. K., Goldman, R. B., Sinatra, S. T., & BHAGAVAN, H. N. (1998) · PubMed · Cited by 105
Self-citationPlasma ubiquinol-10 is decreased in patients with hyperlipidaemia
Kontush, A., Reich, A., Baum, K., Spranger, T., Finckh, B., Kohlschütter, A., & Beisiegel†, U. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06021-2 · Cited by 102
Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris
Kamikawa, T., Kobayashi, A., Yamashita, T., Hayashi, H., & Yamazaki, N. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90843-4 · Cited by 99
Lipid Peroxides as the Initiating Factor of Atherosclerosis
NATTO, C., Kawamura, M., & Yamamoto, Y. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb38723.x · Cited by 85
Hormonal and metabolic reactions evoked by acute myocardial infarction.
Ceremuzyński, L. (1981) · Circulation Research · doi:10.1161/01.res.48.6.767 · Cited by 82
(1997) · PubMed · Cited by 65
Coenzyme Q10 and antioxidants in acute myocardial infarction
Kuklinski, B., Weissenbacher, E. R., & Fähnrich, A. (1994) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(94)90023-x · Cited by 60
Yokoyama, H., Lingle, D. M., Crestanello, J. A., Kamelgard, J. I., Kott, B., Momeni, R., Millili, J. J., Mortensen, S. A., & Whitman, G. J. R. (1996) · Surgery · doi:10.1016/s0039-6060(96)80287-x · Cited by 58
Studies On The Role Of Ubiquinone In The Control Of The Mitochondrial Respiratory Chain
Lenaz, G., Battino, M. A., Castelluccio, C., Fato, R., Cavazzoni, M., Rauchová, H., Bovina, C., Formiggini, G., & Castelli, G. P. (1990) · Free Radical Research Communications · doi:10.3109/10715769009053365 · Cited by 55
Coenzyme Q can control the efficiency of oxidative phosphorylation.
Battino, M. A., Fato, R., Parenti-Castelli, G., et al. (1990) · PubMed · Cited by 52
Singh, R. B., Niaz, M. A., Sharma, J. P., Kumar, R., Bishnoi, I., & Beegom, R. (1994) · PubMed · Cited by 50
Self-citationReperfusion injury after acute myocardial infarction
Grech, E. D., Jackson, M. J., & Ramsdale, D. R. (1995) · BMJ · doi:10.1136/bmj.310.6978.477 · Cited by 44
Serebruany, V. L., Ordonez, J. V., Herzog, W. R., Rohde, M., Mortensen, S. A., Folkers, K., & Gurbel, P. A. (1997) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199701000-00003 · Cited by 31
Coenzyme Q in cardiovascular disease.
Singh, R., Niaz, M. A., Rastogi, V., & Rastogi, S. S. (1998) · PubMed · Cited by 28
Self-citationCoenzyme Q10 protects ischemic myocardium in an open-chest swine model
Atar, D., Mortensen, S. A., Flachs, H., & Herzog, W. (1993) · Journal of Molecular Medicine · doi:10.1007/bf00226849 · Cited by 25
Mazzola, C., Guffanti, E. E., Vaccarella, A., Meregalli, M., Colnago, R., Ferrario, N., Cantoni, V., & Marchetti, G. (1987) · Current Therapeutic Research · Cited by 12
Myocardial preservation, preconditioning, and adaptation
Das, D. K., Engelman, R. M., & Cherian, K. M. (1996) · New York Academy of Sciences eBooks · Cited by 6
Increased Myocardial Tolerance to Ischemia‐Reperfusion Injury by Feeding Pigs with Coenzyme Q10
Yoshida, T., Maulik, G., Bagchi, D., DASH, S. K., Engelman, R. M., & Das, D. K. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb33532.x · Cited by 5
Muscle characteristics in effort angina before and after CABG.
Karlsson, J., Lin, L., Gunnes, S., Sylvén, C., Åström, H., Jansson, E., & Semb, B. K. H. (1997) · PubMed · Cited by 2
Research works printed but not linked: 8
- Herzog WR, Schlossberg ML, Mortensen SA, Serebruany VL. Dietary supplementation with coenzyme Q10 reduces platelet aggregability in swine Coenzyme Q. Res Biol Med 1995;3:5-8.
- Hofman-Bang C, Rehnqvist N, Swedberg K, Astrom H. Coenzyme Q10 as an adjunctive in treatment of congestive heart failure. J Am Coll Cardiol 1992;19(Suppl.):774-776.
- Takasawa K, Fuse K, Konishi T, Watanabe Y. Prevention of premature ventricular contractions with coenzyme Q10 after coronary artery bypass grafting. In: Folkers K, Littami GP, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q. Vol. 6, Amsterdam: Elsevier 1991:357-359.
- Brubacher G, Vuillenmier JP, Incurtis HC, Roth M, eds. Vitamin C: Clinical Biochemistry, Principles and Methods, Vol. 2. Berlin: de Gruyter, 1974:989-997.
- Schardr F, Welzel D, Schess W, Toda K. Effect of coenzyme Q10 on ischemia-induced ST-segment depression: A double blind, placebo controlled crossover study. In: Folkers K, Yamamura Y, eds. Biomedical and Clinical Aspects of Coenzyme Q10, Vol. 5. Amsterdam: Elsevier, 1986:385-394.
- Rosi E, Lombardo A, Testa M, et al. Coenzyme Q10 in ischaemic cardiopathy. In: Folkers K, Littarru GP, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q, Vol. 6. Amsterdam: Elsevier, 1991:321-326.
- Wilson MF, Frishman WH, Giles T, Sethi G, Greenberg SM, Brackett DJ. Coenzyme Q10 therapy and exercise duration in stable angina. In: Folkers K, Littami GP, Yamagami T, eds. Biomedical and Clinical Aspects of Coenzyme Q, Vol. 6. Amsterdam: Elsevier, 1991:339-348.
- Kagan V, Packer L. Electron transport regenerates vitamin E in mitochandria and microsomes via ubiquinone: An antioxidant aduct. In: Corogni F, Banni S, Desai MA, Rice-Evans C, eds. Free Radicals and Antioxidants and Nutrition. London: Richelieu Press, 1993:27-36.
Cited by
Lipidomics reveals a remarkable diversity of lipids in human plasma
Quehenberger, O., Armando, A. M., Brown, A. H., Milne, S. B., Myers, D. S., Merrill, A. H., Bandyopadhyay, S., Jones, K. N., Kelly, S., Shaner, R. L., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m009449 · Cited by 1,341
Risk assessment for coenzyme Q10 (Ubiquinone)
Hathcock, J. N., & Shao, A. (2006) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2006.05.006 · Cited by 114
Sikorska, M., Lanthier, P., Miller, H., Beyers, M., Sodja, C., Zurakowski, B., Gangaraju, S., Pandey, S., & Sandhu, J. K. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.032 · Cited by 70
Carrasco, J., Anglada, F. J., Campos, J. P., Muntané, J., Requena, M. J., & Padillo, J. (2014) · BJU International · doi:10.1111/bju.12485 · Cited by 26
Coenzyme Q9 Provides Cardioprotection after Converting into Coenzyme Q10
Lekli, I., Das, S., Das, S., Mukherjee, S., Bak, I., Juhasz, B., Bagchi, D., Trimurtulu, G., Krishnaraju, A. V., Sengupta, K., et al. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf800035f · Cited by 15
Metadata
- Authors
- Singh, R. B., Wander, G. S., Rastogi, A., Shukla, P. K., Mittal, A., Sharma, J. P., Mehrotra, S. K., Kapoor, R., & Chopra, R. K.
- Venue
- Cardiovascular Drugs and Therapy
- Published
- 1998-09
- Volume
- 12
- Issue
- 4
- Pages
- 347-353
- ISSN
- 0920-3206
- 1573-7241
- Cited by
- 106
- References
- 27
- Language
- en
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.